• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Portfolio management

Triton, KKR-backed Ambea to acquire Aleris division for SEK 3bn

  • Nicole Tovstiga
  • Nicole Tovstiga
  • 17 October 2018
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Stockholm-listed healthcare provider Ambea, backed by Triton and KKR, has agreed to acquire the care operations of Norwegian healthcare provider Aleris Care.

The care operations of Aleris in Norway, Sweden and Denmark will be acquired by Ambea for a final purchase price of around SEK 3bn.

According to the business, the annual sales for the new group for the period July 2017 to June 2018 amounted to approximately SEK 10.6bn, of which Ambea accounted for SEK 5.9bn and Aleris Care SEK 4.6bn. Adjusted EBITA for the new group during the period amounted to SEK 644m, of which adjusted EBITA for Ambea accounted for SEK 49m and Aleris Care SEK 146m. 

The operations have a combined total of approximately 13,100 full-time employees and 7,690 beds and placements in own management.

Ambea intends to finance the transaction with existing credit facilities and new, secured bank financing from Danske Bank, DNB and Nordea. The largest shareholders in Ambea are ACTR Holding and Actor SCA, controlled by KKR and Triton, which represent around 50.1% of the total number of shares in the company.

The company intends to reduce a portion of the acquisition debt with a rights issue, to which KKR and Triton said they plan to subscribe.

Previous funding
3i wholly acquired Ambea, then Carema, in 2005. Five years later, 3i divested its stake in healthcare and care services provider Ambea in an €850m secondary buyout to Triton. The following year in 2011, the private equity player acquired Finnish-based Mehiläinen, creating the health group Ambea.

Ambea was listed on Nasdaq Stockholm in March 2017 – marking a partial exit for the private equity investors – at an issue price of SEK 75 per share valuing the company at around SEK 5bn.

Triton and KKR sold healthcare service Mehiläinen, the Finnish brand under Ambea, to CVC Capital Partners and co-investors in a deal reportedly valued at €1.8bn in March 2018.

Company
Established in 1987 and headquartered in Oslo, Aleris Care owns and operates hospitals, medical centres and elderly care facilities. It also provides medical services.

People
Triton – Peder Prahl (director).
Ambea – Fredrik Gren (CEO).

Advisers
Equity – Nordea (corporate finance); Vinge (legal); Alvarez & Marsal (financial due diligence).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Portfolio management
  • Nordics
  • Healthcare
  • Sweden
  • Denmark
  • Finland
  • Norway
  • KKR
  • Triton Partners
  • 3i

More on Portfolio management

NorthEdge sells Belfield Group's Usleep
NorthEdge sells Belfield Group's Usleep

Mattress producer is to be acquired by Vita Group, a portfolio company of Strategic Value Partners

  • Portfolio management
  • 28 September 2021
Synova's Mintec buys Kairos
Synova's Mintec buys Kairos

Synova acquired its stake in Mintec from the Peksa family in early 2018

  • Portfolio management
  • 11 August 2021
Clessidra's Botter bolts on Mondodelvino
Clessidra's Botter bolts on Mondodelvino

Combined group expects to reach revenues of €350m in 2020 and further expand its market share

  • Portfolio management
  • 26 April 2021
Bid Equity's Myneva bolts on Patronis, TTS
Bid Equity's Myneva bolts on Patronis, TTS

Social care and healthcare software platform is following a buy-and-build strategy

  • Portfolio management
  • 08 March 2021

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013